In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Related Topics
Advocate’s Corner: October 2024
We are weeks away from election day and there is still work to be done! With Congress in recess until after the election, there is a short window of time … Continued
OCRA’s Panel Talks About Finding Strength in Community in Part 4 of BlackDoctor.org Series
In the fourth installment of this special BlackDoctor.org roundtable series in partnership with Ovarian Cancer Research Alliance, ovarian cancer survivors Tiffani, Vernelia, Camille, and Kristen, share how their involvement with … Continued
OCRA-Funded Research Makes Inroads Toward Effective CAR T-Cell Therapies
A research team, led by Dr. Ugo Cavallaro and supported by OCRA’s 2019 Collaborative Research Development Grant, made progress toward improving immunotherapies for ovarian cancer. Dr. Frances R. Balkwill, a … Continued